Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 Genetics Investing
Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress Genetics Investing
3D Signatures and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration Genetics Investing
3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer Pharmaceutical Investing
Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance Longevity Investing
Fulgent Genetics Slides 27 Percent in Q4 2017 Financial Results, Remains Positive for 2018 Genetics Investing
